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Lymphopenia in hospitalised cases of
leptospirosis
The article published in Clinical Microbiology and
Infection by Jaure´guiberry et al. [1] presented an
interesting description of the clinical ﬁndings for
34 patients hospitalised with leptospirosis in a
hospital from the Pontchaillou area of France. The
most striking ﬁnding was the high frequency of
lymphopenia (< 1000 lymphocytes ⁄mm3), which
was observed for 85% of the leptospirosis patients
analysed. By performing a MedLine search, we
veriﬁed that this ﬁnding had not been reported
previously in the literature. Jaure´guiberry et al.
raised the possibility that this high frequency
of lymphopenia could be speciﬁc to leptospirosis
in the Pontchaillou area, but more deﬁnite
conclusions could not be drawn because of a
lack of published studies from other regions in
which this issue was addressed. In response, we
re-analysed our data for 253 leptospirosis patients
enrolled in a clinical trial [2] conducted in an
infectious disease hospital in the city of Salvador,
Brazil. The percentage of patients (17%) with
lymphocyte counts < 1000 ⁄mm3 at admission was
much lower than the ﬁgure (85%) reported by
Jaure´guiberry et al. Interestingly, our patients
with lymphopenia had a signiﬁcantly lower mean
platelet count than patients with higher leukocyte
counts (133 089 ± 55 203 ⁄mm3 vs. 162 626 ± 95
956 ⁄mm3; p 0.014).
As the frequency of icteric patients was much
higher in our study than in the Pontchaillou study
(94.1% vs. 34.3%), we also assessed whether this
ﬁnding could explain the difference in lymphope-
nia between the studies. However, no signiﬁcant
difference (p 0.910) was observed between the
mean lymphocyte counts of patients with
(2196 ± 1384 ⁄mm3) and without jaundice
(2226 ± 1469 ⁄mm3).
It should be noted that, while the serovar
Copenhageni has been the most frequent serovar
isolated from patients hospitalised in Salvador,
the serovar Grippotyphosa was the serovar
isolated most frequently in the Pontchaillou
hospital [1,3]. Interactions between host immune
response and environmental factors, including
the distribution of serovars, may provide expla-
nations for the differences in the frequency of
lymphopenia between patients hospitalised in
Salvador and those hospitalised in the Pontchail-
lou area of France. The correlation between
lymphocyte and platelet counts suggests that
there are similarities in the factors that mediate
the development of lymphopenia and plaque-
topenia in leptospirosis patients. The prevalence
of lymphopenia in patients with leptospirosis
across regions, and the factors related to any
variations, are important questions for future
research.
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